BNTC EBITDA Margin
Benitec Biopharma Inc · EBITDA Margin
BNTC EBITDA Margin
Latest reported-9615.65%period ending
BNTC TTM EBITDA Margin (-231.26% → -9615.65%)
TTM ebitda margin
High-resolution chart · PNG
BNTC ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -9,615.6475% | |
| -9,933.2734% | |
| -9,477.6978% | |
| -8,760.9712% | |
| 617,283.3333% | |
| 430,983.3333% | |
| 364,116.6667% | |
| 365,650% | |
| -301,771.4286% | |
| -35,032.7869% | |
| -26,692% | |
| -25,612% | |
| -28,873.5294% | |
| -29,819.3548% | |
| -24,416.4384% | |
| -24,361.6438% | |
| -22,057.3333% | |
| -61,371.4286% | |
| -390,550% | |
| -22,505.0847% | |
| -72,505.8824% | |
| -19,085.7551% | |
| -6,830.3543% | |
| -6,465.3686% | |
| -882.1563% | |
| -481.3526% | |
| -24.344% | |
| 21.1531% | |
| 21.0912% | |
| 24.2703% | |
| -17.5401% | |
| -500.0215% | |
| -1,725.2785% | |
| -1,033.1455% | |
| -1,461.4946% | |
| -834.7047% | |
| -1,184.9857% | |
| -2,377.3513% | |
| -3,548.2069% | |
| -4,025.2769% | |
| -2,753.1687% | |
| -3,113.9605% | |
| -1,772.6282% | |
| -1,265.2045% | |
| -716.3185% | |
| -496.7929% | |
| -515.309% | |
| -534.8808% | |
| -510.0259% | |
| -477.5751% | |
| -336.5801% | |
| -231.257% |